| 摘要 |
The present invention relates to pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formulawherein X, Y, A, B and R<1 >are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
|
